Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2022 Nov 30;32(4):468–474. doi: 10.1002/pds.5574

TABLE 2.

Validation of non-live birth outcome algorithms

Analysis No. of cases reviewed % retained No. of true cases % retained PPV (95% CI), %
Stillbirth
Primary definition: ≥ 1 inpatient codes 100 71 71.0 (61.1–79.6)
 Exclude cases with codes for other pregnancy outcomes within ±5 days 72 72.0% 58 81.7% 80.6 (69.5–88.9)
Spontaneous abortion
Primary definition: ≥ 1 inpatient or ≥2 outpatient codes 100 79 79.0 (69.7–86.5)
 Exclude cases with codes for other pregnancy outcomes within ±5 days 59 59.0% 51 64.6% 86.4 (75.0–94.0)
Secondary definition: ≥ 1 inpatient or outpatient codes 250 193 77.2 (71.5–82.3)
 Exclude cases with codes for other pregnancy outcomes within ±5 days 171 68.4% 148 76.7% 86.6 (80.5–91.3)
Termination
Primary definition: ≥ 1 inpatient or ≥2 outpatient codes 100 93 93.0 (86.1–97.1)
 Exclude cases with codes for other pregnancy outcomes within ±5 days 85 85.0% 83 89.2% 97.7 (91.8–99.7)
Secondary definition: ≥ 1 inpatient or outpatient codes 277 234 84.5 (79.7–88.5)
 Exclude cases with codes for other pregnancy outcomes within ±5 days 217 78.3% 206 88.0% 94.9 (91.1–97.4)
Composite non-live birth outcomes
Primary definition 297a 274 92.3 (88.6–95.0)
Secondary definition 623b 588 94.4 (92.3–96.1)
a

Out of 300 potential non-live birth cases, 3 duplicates were removed as they were selected for more than one non-live birth sample for validation. This duplication occurred because each non-livebirth cohort was created independently, and codes indicative of different non-live birth outcomes could have been recorded close in time. For the composite non-live birth outcome, a case was considered to be a true positive as long as the non-live birth outcome was confirmed, regardless of the specific type of non-live birth.

b

Out of 627 potential non-live birth cases, 4 duplicates were removed as they were selected for more than one non-live birth sample for validation.